Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
India already has more than 77 million people with type-2 diabetes and one of the world's largest populations of overweight adults
This matters especially because weight loss doesnt always tell the full story: significant weight loss, particularly with GLP-1 medications, can result in muscle loss, with 30 to 40% of the weight lost potentially coming from lean mass
Therapies for inter-relating diabetes and obesity GLP-1 and obesity
For semaglutide users, this translates to a practical benefit
BPC-157 + TB-500 Spray vs Injectable Blend The spray format is particularly well-suited for gut-focused applications (where BPC-157s oral stability and direct GI contact are advantages) and for protocols where daily compliance over weeks is critical (where the convenience of spray vs injection is meaningful)
